9 Ways to Manage Parkinson’s Dyskinesia and Improve Symptoms

Managing dyskinesia in advanced Parkinson’s disease requires a nuanced clinical balance between controlling motor symptoms and mitigating the involuntary, fluid movements triggered by long-term dopaminergic therapy. According to the American Parkinson Disease Association (APDA), dyskinesia is not an indication that levodopa has failed, but rather a sign that the medication is active and the brain is struggling to process peak plasma concentrations.

Pharmacological Adjustments and Continuous Drug Delivery

Because peak-dose dyskinesia occurs when medication efficacy is highest, altering how dopaminergic drugs enter the bloodstream is a primary clinical strategy. According to clinical guidelines, doctors may split daily medication into smaller, more frequent doses or switch patients to extended-release formulations of levodopa to reduce motor fluctuations. When oral regimens fall short, continuous drug delivery systems bypass gastric absorption entirely. The U.S. Food and Drug Administration approved foscarbidopa and foslevodopa (Vyalev) as a continuous subcutaneous 24-hour infusion for adults with advanced Parkinson’s disease, providing a steady baseline of medication to smooth out off-times and limit dyskinetic episodes. Alternatively, Duopa delivers carbidopa-levodopa directly into the small intestine through a surgical stoma, while continuous subcutaneous apomorphine infusions offer another pathway to stabilize dopamine receptor stimulation, per the APDA.

Dietary Interactions and Medication Timing

Dietary protein directly impacts how the body absorbs levodopa, since the medication competes with amino acids for intestinal uptake. Eating a protein-heavy meal alongside a levodopa dose can blunt absorption, forcing higher dosages that subsequently escalate dyskinesia risk. Clinical care teams frequently recommend a low-protein diet or a protein redistribution model—such as consuming the bulk of daily protein at dinner—to maximize bioavailability. Furthermore, iron supplements can impair levodopa absorption and should be spaced at least two hours apart from Parkinson’s medications, while taking standard pills on an empty stomach 30 minutes before or 60 minutes after a meal optimizes drug efficacy.

Surgical Interventions: Deep Brain Stimulation

When pharmacological optimization reaches its threshold, surgical intervention offers substantial relief for refractory movement symptoms. Deep brain stimulation (DBS) involves placing thin electrodes into specific subcortical regions of the brain, connected to a neurostimulator implanted near the collarbone to deliver targeted electrical impulses. According to Dr. Alex Pantelyat, an associate professor of neurology at the Johns Hopkins School of Medicine in Baltimore, deep brain surgery holds the greatest promise on an individual level, though potential surgical risks include intracranial bleeding, brain trauma, or transient verbal memory deficits. Successfully implanted patients often require lower overall medication doses post-surgery, which subsequently dampens dyskinesia severity.

Lifestyle, Sleep Hygiene, and Adjunctive Care

Non-pharmacological factors significantly influence the frequency and severity of involuntary movements. Sleep deprivation exacerbates dyskinesia, yet patients with Parkinson’s average just over five hours of sleep per night and experience frequent nocturnal awakenings due to motor stiffness and cramping, according to APDA data. Maintaining a strict sleep-wake schedule and limiting daytime napping to one short session helps stabilize circadian rhythms. Additionally, large-scale patient surveys demonstrate that stress worsens all Parkinson’s symptoms, including dyskinesia. Incorporating mindfulness practices and structured physical activity—such as walking, cycling, swimming, yoga, Pilates, tai chi, or seated exercises utilizing walking poles and caregiver assistance—mitigates stress and improves overall health-related quality of life, as outlined in studies.